Skip to main content
Equibles
LQDA logo

LQDA · Liquidia Corp

Track LQDA — free

Use LQDA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about LQDA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$74.44 +2.34 (+3.25%) At close · Aug 14
Market Cap
$6.66B
Shares
89.51M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$74.44 Open$71.98 Day$71.53–76.90 52W close$21.80–91.03 Avg vol 30d1.6M Short int12.0M · 13.4% float · 8.3d Short vol43% Last earningsAug 12, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 12

Up next

Next earnings call
Nov 8, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 12, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +55%
      above
      Price vs 50-day avg −5%
      below
      RSI (14) 40
      neutral
      MACD trend Negative
      52-week position 76%
      mid-range
      Momentum
      relative strength
      Strong
      1-month return −7%
      trailing
      6-month return +127%
      trailing
      YTD return +116%
      this year
      Relative strength +114%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $78 › 200d $48 — 50d above 200d
      Institutional flow Accumulating
      +33% holders QoQ · +126 funds added
      Insider flow Distributing
      Net -$116.4M over 90 days · 83% sells
      Short interest Falling
      13.37% of float · ▼ -3.0% MoM · 8.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      335 holders — near 3-yr high, broad support
      Squeeze score 75
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +1031%
      Y/Y
      EPS growth +51%
      Y/Y
      Free cash flow $-40.0M
      Balance sheet $170.8M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 65%
      annualized · 1-yr
      Max drawdown −36%
      past year
      ATR 7.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Mar 31, 2026
      Net revenue · 2027 $1B

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +55% Bullish
      Price vs 50-day avg
      −5% Neutral
      RSI (14)
      40 Neutral
      MACD trend
      Negative Bearish
      52-week position
      76% Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $78 › 200d $48 — 50d above 200d
      Institutional flow Accumulating
      +33% holders QoQ · +126 funds added
      Insider flow Distributing
      Net -$116.4M over 90 days · 83% sells
      Short interest Falling
      13.37% of float · ▼ -3.0% MoM · 8.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      335 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $22 Now $74 · 76% Range high $91
      vs 200-day avg +55% vs 50-day avg -5%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP Net income 74.72M
      +3.82M Interest expense, net
      +6.98M Income tax expense
      +400K Depreciation and amortization
      +10.37M Stock-based compensation
      = Adjusted EBITDA 96.29M
      Cash Balance $284.2M Q2 2026 —
      Net product sales annualized run-rate $682M Q2 2026 —
      Patients started on treatment since launch 5,000 as of July 31, 2026 —
      Prescribers 1,100 as of July 31, 2026 —
      Total prescribers since launch 1,100 as of July 31, 2026 —
      Unique patient prescriptions since launch 5,900 as of July 31, 2026 —
      Patients treated since launch 2,900 as of February 28, 2026 —
      Unique prescriptions received since launch 3,600 as of February 28, 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Drug Manufacturers - Specialty & Generic — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      LQDA
      Liquidia Corp
      this stock
      		$6.66B +115.8% +1031.2% — 13.4%
      JHPCY
      Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
      		 $64.91B — — — 0.0%
      TAK
      Takeda Pharmaceutical Co Ltd
      		 $56.30B +13.1% — — 0.1%
      GALDY
      Galderma Group AG/ADR
      		 $49.49B +2.4% — — 0.0%
      TEVA
      Teva Pharmaceutical Industries Ltd
      		 $42.85B +17.8% +4.3% 60.3 2.9%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      335
      % held
      88.6%
      Net QoQ
      +11.4M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      190
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      12.0M
      Days to cover
      8.3d
      Change
      -370.2K sh
      View
      Short Volume
      Short vol %
      43%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      98
      Value
      $7.8K
      As of
      Jul 7, 2026
      View
      Off-Exchange
      Off-exchange %
      38.9%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$116.4M
      Buyers / Sellers
      1 / 5
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $158.3M
      Net income (FY)
      $-68.9M
      EPS diluted
      $-0.80
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 12, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $1.6M
      Shares
      24.9K
      Filed
      Jun 11, 2026
      View
      Exempt Offerings
      Offering
      $21.7M
      Filed
      Apr 16, 2021
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 12, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      LQDA -17.5% -6.9% +127.4% -11.5% +115.8%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -17.9% -11.3% +113.6% -15.4% +102.0%
      Key facts CIK 1819576 CUSIP 53635D202 13F (30d) 315 filings 314 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)